KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Current Assets (2017 - 2025)

Historic Current Assets for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $303.9 million.

  • Twist Bioscience's Current Assets fell 1199.71% to $303.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $303.9 million, marking a year-over-year decrease of 1199.71%. This contributed to the annual value of $333.0 million for FY2025, which is 398.24% down from last year.
  • Twist Bioscience's Current Assets amounted to $303.9 million in Q4 2025, which was down 1199.71% from $333.0 million recorded in Q3 2025.
  • Over the past 5 years, Twist Bioscience's Current Assets peaked at $664.4 million during Q1 2022, and registered a low of $303.9 million during Q4 2025.
  • Moreover, its 5-year median value for Current Assets was $407.2 million (2023), whereas its average is $451.7 million.
  • Data for Twist Bioscience's Current Assets shows a peak YoY increase of 13366.15% (in 2021) and a maximum YoY decrease of 3931.43% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Twist Bioscience's Current Assets stood at $385.0 million in 2021, then surged by 40.74% to $541.9 million in 2022, then decreased by 27.98% to $390.2 million in 2023, then decreased by 11.51% to $345.3 million in 2024, then decreased by 12.0% to $303.9 million in 2025.
  • Its last three reported values are $303.9 million in Q4 2025, $333.0 million for Q3 2025, and $339.8 million during Q2 2025.